AstraZeneca and BenevolentAI May Have Found a New CKD Treatment Using AI
As reported in Biospace, a collaboration between biopharmaceutical company AstraZeneca and BenevolentAI has for the first time used AI to identify a molecule that plays a key role chronic kidney…